孕晚期普遍超声筛查臀先露:前瞻性队列研究与成本效果分析
本研究基于3879名初产妇的前瞻性队列,在36周妊娠时评估胎儿先露,并对检出的臀先露常规尝试外倒转。经济模型分析显示,普遍晚孕期超声可几乎消除未诊断臀先露,减少急诊剖宫产和阴道臀位分娩,并可能降低新生儿死亡率,若每名妇女评估费用不超过19.80英镑则具成本效果。
要点
- 36周普遍超声检出臀先露179例(4.6%),其中96例此前未怀疑非头位。
- 外倒转尝试84例,成功12例(成功率14.3%);平均每40次超声检出1例新发臀先露。
- 普遍超声预计每年减少急诊剖宫产0.7个百分点、阴道臀位分娩1.0个百分点,并预防7.89例新生儿死亡。
核心结论
- 作者估计,对初产妇进行普遍晚孕期超声可几乎消除未诊断臀先露,预期降低臀先露胎儿死亡率,且若每名妇女评估费用低于19.80英镑则具成本效果。
研究设计与样本
- 妊娠结局预测(POP)研究为前瞻性队列研究,纳入2008年1月14日至2012年7月31日期间3879名在36周妊娠时接受研究性筛查超声的初产妇。
- 构建概率经济模拟模型,比较普遍超声与当前实践的不同分娩方式可能性及长期健康结局,参数来自POP研究,成本主要来自英国国家医疗服务体系(NHS)。
主要发现
- 3879名妇女中179名(4.6%)在36周诊断臀先露,其中96名此前无先露异常怀疑。
- 84名(46.9%)尝试外倒转,成功12名(成功率14.3%);179名中阴道分娩19名(10.6%)、择期剖宫产110名(61.5%)、急诊剖宫产50名(27.9%)。
- 整个队列中无分娩时未诊断臀先露;平均每40次超声检出1例既往未诊断的臀先露。
- 经济分析显示,与当前实践相比,普遍晚孕期超声每年在英格兰发现约14826例未诊断臀先露,减少急诊剖宫产0.7个百分点(每年约4196例)和阴道臀位分娩1.0个百分点(每年约6061例),并每年预防7.89例新生儿死亡。
- 若每名妇女胎儿先露评估费用≤19.80英镑,该策略具成本效果。
关键数值与推荐
- 若每名妇女胎儿先露评估费用≤19.80英镑,普遍晚孕期超声具成本效果。
- 检出臀先露后常规提供外倒转;若外倒转失败或未进行,提供39周择期剖宫产或尝试阴道臀位分娩。
临床怎么用
- 原文未据此给出推荐。
局限性
- 胎儿先露向所有妇女揭示。
- 卫生经济学分析可能受产次影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the relative ease with which breech presentation can be identified through ultrasound screening, the assessment of foetal presentation at term is often based on clinical examination only. Due to limitations in this approach, many women present in labour with an undiagnosed breech presentation, with increased risk of foetal morbidity and mortality. This study sought to determine the cost effectiveness of universal ultrasound scanning for breech presentation near term (36 weeks of gestational age [wkGA]) in nulliparous women. METHODS AND FINDINGS: The Pregnancy Outcome Prediction (POP) study was a prospective cohort study between January 14, 2008 and July 31, 2012, including 3,879 nulliparous women who attended for a research screening ultrasound examination at 36 wkGA. Foetal presentation was assessed and compared for the groups with and without a clinically indicated ultrasound. Where breech presentation was detected, an external cephalic version (ECV) was routinely offered. If the ECV was unsuccessful or not performed, the women were offered either planned cesarean section at 39 weeks or attempted vaginal breech delivery. To compare the likelihood of different mode of deliveries and associated long-term health outcomes for universal ultrasound to current practice, a probabilistic economic simulation model was constructed. Parameter values were obtained from the POP study, and costs were mainly obtained from the English National Health Service (NHS). One hundred seventy-nine out of 3,879 women (4.6%) were diagnosed with breech presentation at 36 weeks. For most women (96), there had been no prior suspicion of noncephalic presentation. ECV was attempted for 84 (46.9%) women and was successful in 12 (success rate: 14.3%). Overall, 19 of the 179 women delivered vaginally (10.6%), 110 delivered by elective cesarean section (ELCS) (61.5%) and 50 delivered by emergency cesarean section (EMCS) (27.9%). There were no women with undiagnosed breech presentation in labour in the entire cohort. On average, 40 scans were needed per detection of a previously undiagnosed breech presentation. The economic analysis indicated that, compared to current practice, universal late-pregnancy ultrasound would identify around 14,826 otherwise undiagnosed breech presentations across England annually. It would also reduce EMCS and vaginal breech deliveries by 0.7 and 1.0 percentage points, respectively: around 4,196 and 6,061 deliveries across England annually. Universal ultrasound would also prevent 7.89 neonatal mortalities annually. The strategy would be cost effective if foetal presentation could be assessed for £19.80 or less per woman. Limitations to this study included that foetal presentation was revealed to all women and that the health economic analysis may be altered by parity. CONCLUSIONS: According to our estimates, universal late pregnancy ultrasound in nulliparous women (1) would virtually eliminate undiagnosed breech presentation, (2) would be expected to reduce foetal mortality in breech presentation, and (3) would be cost effective if foetal presentation could be assessed for less than £19.80 per woman.
引用
- Wastlund D, Moraitis AA, Dacey A, et al. Screening for breech presentation using universal late-pregnancy ultrasonography: A prospective cohort study and cost effectiveness analysis. PLoS Med. 2019. PMID: 30990808. doi:10.1371/journal.pmed.1002778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。